Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era

by Joseph Abi Jaoude, MD, Connor P. Thunshelle, BS, Ramez Kouzy, MD, Nicholas D. Nguyen, BA, Daniel Lin, BA, Laura Prakash, MD, Isabela M. Bumanlag, BS, Sonal S. Noticewala, MD, Joshua S. Niedzielski, PhD, Sam Beddar, PhD, Ethan B. Ludmir, MD, Emma B. Holliday, MD, Prajnan Das, MD, MS, MPH, Bruce D. Minsky, MD, Joseph M. Herman, MD, Matthew Katz, MD, Albert C. Koong, MD, PhD, Eugene J. Koay, MD, PhD, Cullen M. Taniguchi, MD, PhD
Published 2021-11-01

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer

by Shalini Moningi, MD, Joseph Abi Jaoude, MD, Ramez Kouzy, MD, Daniel Lin, BA, Nicholas D. Nguyen, BA, Carolina J. Garcia Garcia, BS, Jae L. Phan, BA, Santiago Avila, BA, Daniel Smani, BA, Irina M. Cazacu, MD, Ben S. Singh, BA, Grace L. Smith, MD, PhD, MPH, Emma B. Holliday, MD, Eugene J. Koay, MD, PhD, Prajnan Das, MD, MS, MPH, Manoop S. Bhutani, MD, Joseph M. Herman, MD, MSc, MSHM, Bruce D. Minsky, MD, Albert C. Koong, MD, PhD, Cullen M. Taniguchi, MD, PhD
Published 2021-03-01